Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Atherectomy is a minimally invasive procedure that removes plaque from vessels. devices have been developed to facilitate this technique, to cut the plaque from the artery walls using orbital, rotational, laser, and directional techniques. GlobalData uses proprietary data and analytics to provide a comprehensive report on the atherectomy devices market in Belgium. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the atherectomy devices market in Belgium was AngioDynamics followed by Avinger, Becton Dickinson and Co, Boston Scientific, Cardiovascular Systems, Koninklijke Philips and Medtronic.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Atherectomy is especially valuable in eliminating highly calcified plaque. The Atherectomy procedure may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting. Coronary Atherectomy devices and Lower Extremity Peripheral Atherectomy devices are covered under this category. Coronary Atherectomy devices include Coronary Rotational Atherectomy devices, Coronary Directional Atherectomy devices, Coronary Orbital Atherectomy devices and Coronary Laser Atherectomy devices. Lower Extremity Peripheral Atherectomy devices include Peripheral Rotational Atherectomy devices, Peripheral Directional Atherectomy devices, Peripheral Orbital Atherectomy devices and Peripheral Laser Atherectomy devices.

The atherectomy devices market in Belgium can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size atherectomy devices in Belgium, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.